Literature DB >> 12656408

Outcome of treatment with valacyclovir and prednisone in patients with Bell's palsy.

Sara Axelsson1, Sven Lindberg, Anna Stjernquist-Desatnik.   

Abstract

Idiopathic facial paralysis, or Bell's palsy, shows a nonepidemic pattern that might indicate reactivation of a latent microorganism such as herpes simplex type I as a causative agent. Thirty percent of patients with Bell's palsy given no treatment will not recover completely, and 5% will have severe sequelae. The aim of this study was to find out whether treatment with an antiviral drug in combination with corticosteroids is more effective than no medical treatment at all in patients with Bell's palsy. Fifty-six consecutive adult patients attending the otorhinolaryngology department of the University Hospital of Lund from 1997 to 1999 were treated with 1 g of valacyclovir hydrochloride 3 times per day for 7 days and 50 mg of prednisone daily for 5 days, with the dose being reduced by 10 mg daily for the next 5 days. Fifty-six adult patients with Bell's palsy attending the same department between 1995 and 1996 who were given no medical treatment were studied retrospectively and used as the control group. Forty-nine patients (87.5%) in the treatment group recovered completely, as compared with 38 patients (68%) in the control group (p < .05). One patient (1.8%) in the treatment group displayed severe sequelae, defined as a House-Brackmann score of IV or worse, as compared with 10 of 56 patients (18%) in the control group (p < .01). Among patients over 60 years old, 10 of 10 in the treatment group had complete recovery, as compared with 5 of 12 patients in the control group (p < .01). The present study showed a significantly better outcome in patients with Bell's palsy treated with valacyclovir and prednisone as compared with patients given no medical treatment. This difference in outcome was especially pronounced among elderly patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656408     DOI: 10.1177/000348940311200301

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  11 in total

Review 1.  Recent developments in Bell's palsy.

Authors:  N Julian Holland; Graeme M Weiner
Journal:  BMJ       Date:  2004-09-04

2.  Recent developments in Bell's palsy: does a more recent single research paper trump a systematic review?

Authors:  James A Cave
Journal:  BMJ       Date:  2004-11-06

Review 3.  Modern management of facial palsy: a review of current literature.

Authors:  Benjamin Stew; Huw Williams
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

4.  Idiopathic diaphragmatic paralysis: Bell's palsy of the diaphragm?

Authors:  Robert S Crausman; Eleanor M Summerhill; F Dennis McCool
Journal:  Lung       Date:  2009-03-10       Impact factor: 2.584

Review 5.  Bell's palsy.

Authors:  Julian Holland
Journal:  BMJ Clin Evid       Date:  2008-01-02

6.  The Effectiveness of Neural Therapy in Patients With Bell's Palsy.

Authors:  Ferdi Yavuz; Bayram Kelle; Birol Balaban
Journal:  Integr Med (Encinitas)       Date:  2016-06

7.  Antiviral treatment for Bell's palsy (idiopathic facial paralysis).

Authors:  Ildiko Gagyor; Vishnu B Madhok; Fergus Daly; Frank Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

Review 8.  Management of peripheral facial nerve palsy.

Authors:  Josef Finsterer
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-27       Impact factor: 2.503

9.  Bell's palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone.

Authors:  Martina Minnerop; Martin Herbst; Rolf Fimmers; Pavlina Kaabar; Bertfried Matz; Thomas Klockgether; Ullrich Wüllner
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 6.682

10.  Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell's Palsy.

Authors:  Ali Khajeh; Afshin Fayyazi; Gholamreza Soleimani; Ghasem Miri-Aliabad; Sara Shaykh Veisi; Behrouz Khajeh
Journal:  Iran J Child Neurol       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.